Summary of Weili Medical Conference Call Company Overview - Weili Medical focuses on three main product lines: anesthesia, catheterization, and urology, with anesthesia products having the highest share [2][4]. Market Revenue Distribution - The revenue distribution between domestic and international markets is nearly 50-50 [2][5]. - The international market primarily operates on an OEM basis, serving major global clients such as Menline, Cardinal, ConvaTec, B. Braun, and Medtronic, with stable order growth and active new client acquisition [2][5]. International Market Performance - Weili Medical has significantly improved its gross margin in overseas operations by diversifying its OEM product categories [2][3]. - Following the resolution of tariff issues in April 2025, overseas shipments have returned to normal, and the company plans to establish production capacity in Southeast Asia to mitigate tariff impacts [2][5]. Domestic Market Developments - In the domestic market, Weili Medical is upgrading its product pipeline, introducing new products such as the visual double-lumen catheter in anesthesia, ultra-smooth and BIP antibacterial coated catheters in catheterization, and enhancing stone extraction sheaths in urology [2][6]. - The company is also venturing into male health products, including a foreskin relief device and ED treatment instruments [2][6]. - Despite the impact of anti-corruption measures on inpatient sales, Weili Medical continues to advance product upgrades and channel expansion [2][6]. Future Outlook - The future development prospects for Weili Medical are viewed positively, as the company transitions from low-value consumables to high-value consumables, enhancing profitability through product line expansion [3][7]. - Both domestic and international markets exhibit strong growth momentum, with significant gross margin improvements achieved through the OEM model and new client development in international markets [3][7].